
Aug 21, 2026 · 43 min
Markets test biotech promise and AI’s trillion-dollar ambitions
Cancer Vaccines & Data Center Drama
The episode connects higher rates and tougher capital markets with uncertain breakthroughs, inflated private-company valuations, and mounting resistance to AI infrastructure.
- 1Higher rates raise discount rates and borrowing costs, making debt-heavy companies and ambitious investment cases harder to justify.
- 2Moderna and Merck’s cancer-vaccine results look medically important, but biotech uncertainty and optimistic pricing remain central risks.
- 3The hosts question AI valuations, Tesla’s scale, Bitcoin’s utility, and whether data centers can earn community support.
Don't miss
The hosts weigh Moderna and Merck’s cancer-vaccine results against the uncertainty of biotech outcomes and the risk that optimism is already priced in.
The brief
Travis Holy, Lou Whiteman, and Jim Gillies begin with the bond market’s power over borrowing costs, arguing that debt supply, deficits, and higher discount rates shape valuations beyond policymakers’ control.
Moderna and Merck’s phase-three cancer-vaccine results offer a potentially important medical breakthrough, but the hosts stress uncertain biotech outcomes and the possibility that investors have already priced in the optimism.
The valuation game turns to Anthropic, OpenAI, Bitcoin, Disney, and Tesla, testing how much future growth, cash flow, utility, or brand strength investors should pay for today.
Data centers face backlash over their footprint, resource demands, incentives, and perceived arrogance, raising a practical question: can AI infrastructure win communities over before it expands further?
Peloton and Union Pacific close the discussion as contrasting ideas: one a possible turnaround beneath a collapsed stock price, the other a railroad merger facing regulatory and political risk.
What was said on this episode
37 statements · 12 positive · 23 negative · 1 mixed · 1 neutral
Current interest-rate panic is excessive because borrowing should have a cost.
“I think some of the current panic about current rates is overdone because money should cost something.”
Listen at 1:29
Interest rates around 4–5% filter out some bad investment ideas.
“a nice four or 5% rate does provide you some sort of, I don't want to say BS filter”
Listen at 1:53
U.S. federal government debt has exceeded $40 trillion.
“Federal government debt in the U.S. just passed the $40 trillion mark.”
Listen at 5:20
U.S. federal debt interest consumes about 20% of incoming federal tax revenue.
“Interest on that debt is already sucking up about 20 cents of every federal tax dollar coming in.”
Listen at 5:26
The bond market will recognize the Treasury’s debt-management maneuver.
“the bond market is going to see through this.”
Listen at 7:32
The bond market is currently skeptical of worsening debt conditions.
“the bond market's going, eh, we're not really sure about this.”
Listen at 8:34
Debt supply is currently abundant across markets.
“there is just a lot of supply of debt right now.”
Listen at 8:46
Government debt is a serious but long-term investment problem.
“This is a serious problem, but it is a long-term problem as an investor.”
Listen at 10:16
Higher discount rates reduce present valuations.
“the higher the discount rate, the lower the present valuation will be.”
Listen at 12:38
Moderna’s stock rose approximately 140% during the week.
“Moderna stocks up about 140% this week.”
Listen at 15:39
Moderna and Merck’s cancer-vaccine results could benefit humanity.
“This is great news for humanity.”
Listen at 16:18
The cancer-vaccine optimism is largely reflected in Moderna’s stock price.
“I do think it's kind of quote unquote priced in.”
Listen at 16:26
Biotech investors should diversify across companies.
“if you want to play in biotech, maybe it's best to spread your bets around”
Listen at 19:02
AI currently lacks biological understanding, and developing it will take time.
“AI knows English. AI doesn't know biology. That's going to take some time.”
Listen at 20:03
Anthropic appears too uncertain to buy confidently at nearly any valuation.
“I would be very gun-shy almost at any valuation”
Listen at 24:26
Most IPOs underperform during their first few years as public companies.
“most IPOs underperform for the first couple of years of going public.”
Listen at 26:18
Investors should avoid IPOs until cash flow, profitability, and hype conditions improve.
“you probably want to avoid playing an IPO space until you know, there is cash flows and there is profitability and the hype goes away.”
Listen at 26:25
An OpenAI IPO may never occur.
“I am not 100% convinced there will ever be an OpenAI IPO at this point.”
Listen at 26:49
At equal prices, Anthropic is preferable to OpenAI.
“At the same price right now, Anthropic.”
Listen at 27:00
Bitcoin currently lacks a useful function.
“My problem with Bitcoin is that it doesn't do anything.”
Listen at 27:23
Bitcoin might warrant a small speculative investment at a much lower price.
“I'd probably just throw money in.”
Listen at 27:49
Disney should separate its parks, experiences, and cruise ships into an independent company.
“they need to just spin out the parks and the experiences, all of that, the cruise ships as an independent company”
Listen at 28:25
Disney’s current collection of businesses does not work effectively.
“I don't think this business works.”
Listen at 28:42
Disney has substantially enriched Bob Iger over much of two decades.
“Disney has been used as a Bob Iger enrichment scheme for much of the last two decades.”
Listen at 29:42
Disney park price growth exceeded inflation by about 10 percentage points for roughly three decades.
“The inflation. The pace at which going to Disney parks has outpaced the rate of inflation by about 10 percentage points for something like three decades.”
Listen at 30:13
Disney’s buybacks may not be occurring at an attractive valuation.
“I'm not sure Disney's there.”
Listen at 31:05
Disney’s brands remain strong, but the investment has performed poorly for years.
“The brands are great and it's just, it hasn't worked for a long time.”
Listen at 32:39
Tesla’s growth has ended.
“with Tesla, the growth is gone”
Listen at 33:42
Tesla’s operating margins fell from about 19% to approximately 1.4%.
“The operating margins, the profitability margins have cratered. They've gone from 19% a couple of years ago to I think the most recent quarter is 1.4.”
Listen at 33:51
“My price where I would buy Tesla because I think it offers an above market return going forward. The price probably starts with a three or a four and there's only two digits in it.”
Listen at 34:06
Tesla’s fair value is approximately $275 billion in market capitalization.
“my market cap is at 275 billion would be my fair value.”
Listen at 34:39
Big tech is communicating poorly about data-center projects.
“big tech has a messaging problem”
Listen at 38:11
AI has failed to convince consumers that it is necessary or transformative.
“AI has done a terrible job of convincing consumers this is something that's necessary, interesting, world-changing”
Listen at 38:39
Peloton’s stock is down approximately 95% from its pandemic-era level.
“It's a stock that's down 95% from its COVID area time.”
Listen at 39:47
Peloton is nearly debt-neutral and its debt is expected to disappear.
“They're almost debt neutral guys. And it's going to go away.”
Listen at 41:51
Peloton trades below seven times trailing free cash flow.
“the stock today is trading for less than seven times trailing free cash flow.”
Listen at 42:03
Union Pacific’s Norfolk Southern acquisition could close by end-2027.
“it probably could get done by the end of 2027.”
Listen at 42:39
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Books & mentions
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.